Comparison of photodynamic therapy with different excitation wavelengths using a dynamic model of aminolevulinic acid-photodynamic therapy of human skin

Journal of Biomedical Optics

Volumn 17, Issue 8, 2012, Pages

  Liu, Baochang ^a,b   Farrell, Thomas J ^a,b   Patterson, Michael S ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Aminolevulinic acid; Dosimetry; Fluorescence; Photobleaching; Photodynamic therapy; Singlet oxygen luminescence

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; SINGLET OXYGEN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; COMPARATIVE STUDY; COMPUTER SIMULATION; HUMAN; LIGHT; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PHOTOCHEMOTHERAPY; PHOTOSTIMULATION; PHYSIOLOGY; RADIATION EXPOSURE; SKIN ABSORPTION; TISSUE DISTRIBUTION;

AMINOLEVULINIC ACID; ANIMALS; COMPUTER SIMULATION; HUMANS; LIGHT; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; PHOTIC STIMULATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINGLET OXYGEN; SKIN ABSORPTION; TISSUE DISTRIBUTION;

EID: 84874951383     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.8.088001     Document Type: Article

References (20)

1. C. Fritsch et al., "Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses," Photodermatol. Photoimmunol. Photomed. 13(5-6), 181-185 (1997). (Pubitemid 28116607)
2. M. H. Gold, "Acne vulgaris: lasers, light sources and photodynamic therapy-an update 2007," Expert Rev. Anti Infect. Ther. 5(6), 1059-1069 (2007). (Pubitemid 350303033)
3. W. J. Cottrell et al., "Irradiancedependent photobleaching and pain in -aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas," Clin. Cancer Res. 14(14), 4475-4483 (2008).
4. M. H. Gold and M. P. Goldman, "5-aminolevulinic acid photodynamic therapy: where we have been and where we are going," Dermatol. Surg. 30(8), 1077-1083 (2004). (Pubitemid 39120667)
5. C. A. Morton et al., "Comparison of red and green light in the treatment of bowens disease by photodynamic therapy," Br. J. Dermatol. 143(4), 767-772 (2000).
6. K. P. Nielsen et al., "Choice of optimal wavelength for PDT: the significance of oxygen depletion," Photochem. Photobiol. 81(5), 1190-1194 (2005). (Pubitemid 41545945)
7. B. Liu, T. J. Farrell, and M. S. Patterson, "A dynamic model for ALAPDTof skin: simulation of temporal and spatial distributions of groundstate oxygen, photosensitizer and singlet oxygen," Phys. Med. Biol. 55 (19), 5913-5932 (2010).
8. B. Liu, T. J. Farrell, and M. S. Patterson, "Comparison of noninvasive photodynamic therapy dosimetry methods using a dynamic model of ALA-PDT of human skin," Phys. Med. Biol. 57(3), 825-841 (2012).
9. M. T. Jarvi et al., "Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects," Photochem. Photobiol. 82(5), 1198-1210 (2006). (Pubitemid 44701998)
10. E. Salomatina et al., "Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range," J. Biomed. Opt. 11 (6), 1-9 (2006).
11. B. Liu et al., "A Monte Carlo model of detected singlet oxygen luminescence and photosensitizer fluorescence during ALA-PDT of skin," Proc. SPIE 7380, 73806W (2009).
12. I. Georgakoudi and H. T. Foster, "Singlet oxygen-versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry," Photochem. Photobiol. 67(6), 612-625 (1998). (Pubitemid 128471939)
13. K. K.Wang, S. Mitra, and T. H. Foster, "A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy," Med. Phys. 34(1), 282-293 (2007). (Pubitemid 46035250)
14. L. B. Josefsen and R. W. Boyle, "Photodynamic therapy and the development of metal-based photosensitisers," Met. Based Drugs. 2008, 1-24 (2008).
15. J. P. Keene et al., "Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds," Photochem. Photobiol. 43(2), 117-120 (1986).
16. T. L. Becker et al., "Monitoring blood flow responses during topical ALA-PDT," Biomed. opt. Express 2(1), 123-130 (2011).
17. A. M. K. Enejder et al., "Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging," Acta. Derm. Venereol. 80(1), 19-23 (2000). (Pubitemid 30110842)
18. M. A. Herman, D. Fromm, and D. Kessel, "Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans," J. Photochem. Photobiol. B 52(1-3), 99-104 (1999). (Pubitemid 30011501)
19. J. Tyrrell et al., "Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy," Br. J. Dermatol. 165(6), 1323-1331 (2011).
20. I. Wang et al., "Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging," Br. J. Dermatol. 136, 18-49 (1997).